| Biologic predictors in follicular lymphoma: importance of markers of immune response T Kelley, R Beck, A Absi, T Jin, B Pohlman, E Hsi Leukemia & lymphoma 48 (12), 2403-2411, 2007 | 60 | 2007 |
| Highlights of the management of adult histiocytic disorders: Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis HA Salama, AR Jazieh, AY Alhejazi, A Absi, S Alshieban, M Alzahrani, ... Clinical Lymphoma Myeloma and Leukemia 21 (1), e66-e75, 2021 | 39 | 2021 |
| BU-vs TBI-based conditioning for adult patients with ALL M Kalaycio, B Bolwell, L Rybicki, A Absi, S Andresen, B Pohlman, R Dean, ... Bone marrow transplantation 46 (11), 1413-1417, 2011 | 28 | 2011 |
| Prolymphocytic leukemia A Absi, E Hsi, M Kalaycio Current Treatment Options in Oncology 6, 197-208, 2005 | 18 | 2005 |
| Analysis of patient-physician concordance in the understanding of chemotherapy treatment plans among patients with cancer H Almalki, A Absi, A Alghamdi, M Alsalmi, M Khan JAMA Network Open 3 (3), e200341-e200341, 2020 | 15 | 2020 |
| Adult-onset hemophagocytic lymphohistiocytosis type 2 presenting as a demyelinating disease H Algahtani, A Absi, W Bassuni, B Shirah Multiple sclerosis and related disorders 25, 77-82, 2018 | 14 | 2018 |
| Response to imatinib therapy in adult patients with chronic myeloid leukemia in Saudi population: a single-center study E Alsobhi, MB Abrar, M Abdelaal, A Alsaeed, A Absi, Z Alzahrani, ... Leukemia & Lymphoma 56 (4), 882-886, 2015 | 13 | 2015 |
| Optimal Management of Acute Lymphoblastic Leukemia (ALL) in Adult Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic. A Alhuraiji, S Eldadah, F Alfraih, R Pandita, A Absi, A Hanbali, M Aljurf, ... The Gulf Journal of Oncology 1 (33), 7-18, 2020 | 10 | 2020 |
| Outcome and toxicities of modified augmented Berlin-Frankfurt-Muenster (ABFM) therapy used in the treatment of acute lymphoblastic leukemia in adolescent and young adult … S Radi, A Merdad, M Al-Dabbagh, AA Absi, A Alsaeed, I El-Hemaidi Blood 120 (21), 3569, 2012 | 3 | 2012 |
| Comparison of a modified pediatric protocol versus a hyper-CVAD protocol in adolescents and young adults with Philadelphia-negative acute lymphoblastic leukemia: a multicenter … H Salama, S Eldadah, MH Omer, A Alhejazi, LB Dayil, A Almozaini, ... Leukemia Research 130, 107316, 2023 | 2 | 2023 |
| Hyperferritinemia with iron deposition in the basal ganglia and tremor as the initial manifestation of follicular lymphoma H Algahtani, A Absi, B Shirah, H Al-Maghraby, H Algarni International Journal of Neuroscience 133 (8), 896-900, 2023 | 1 | 2023 |
| Outcomes of high‑dose methotrexate for CNS prophylaxis in diffuse large B‑cell lymphoma with an intermediate or high CNS‑International Prognostic Index: A single‑center … M Al-Mansour, A Absi, R Al-Μufti, M Alahmadi, I El-Ηemaidi, S Alamoudi, ... Molecular and Clinical Oncology 17 (6), 159, 2022 | 1 | 2022 |
| Evaluation of tyrosine kinase inhibitor discontinuation initiative in patients with chronic myeloid leukemia at princess noorah oncology center AM Noor, MA Khan, MM Al-Thomali, AH Alnatsheh, AA Absi, FM Hakami, ... Journal of Applied Hematology 13 (3), 126-131, 2022 | 1 | 2022 |
| Autologous peripheral blood stem cell mobilization and collection in patients with lymphoma and multiple myeloma: A single-center experience using the plerixa for pre-emptive … AS Alsaeed, MJ Najib, SM Al Amoudi, IY Elhemaidi, AA Absi, ... Saudi Medical Journal 43 (6), 626, 2022 | 1 | 2022 |
| Guide lines for management of adult histiocytic disease HA Salama, AY Alhejazi, A Absi, S Alshieban, M Alzahrani, A Alaskar, ... Journal of Applied Hematology 9 (4), 111-119, 2018 | 1 | 2018 |
| Treatment of adolescents and young adults with Philadelphia negative acute lymphoblastic leukemia (AYA Ph-ALL) using a risk and response based protocol with extended … S Eldadah, W Jastaniah, A Alsaeed, MB Abrar, MA Abdelaal, Z Alzahrani, ... Journal of Clinical Oncology 35 (15_suppl), e18527-e18527, 2017 | 1 | 2017 |
| Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working Group F Alfraih, A Absi, M Abuhaleeqa, K Alghamdi, A Alhuraiji, M Al‐Khabori, ... Cancer Reports 7 (2), e1931, 2024 | | 2024 |
| Real-World Use of Hypomethylating Agents (HMA)/Venetoclax Combinations in Patients with Myelodysplastic Neoplasms (MDS) in the Arabian Gulf Region F Khadadah, H Cherif, H El Omri, A Absi, N Merwass, MIA Haleeqa, ... Blood 142, 7428, 2023 | | 2023 |
| Evaluation of Efficacy and Safety of Nivolumab in Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma at King Abdulaziz Medical City-Jeddah/the Kingdom of Saudi Arabia … AR Alsafi, M Alahmadi, A Absi, AS Alsaeed, S Alamoudi, I Hemaidi, ... Blood 142, 6175, 2023 | | 2023 |
| 334MO A multicenter retrospective study to understand the clinical characteristics, treatment patterns, and outcomes of CLL patients in the Middle East: A subgroup analysis of … RMA Soliman, A Alhuraiji, Y Buyukasik, M Siddiqui, S Alamoudi, ... Annals of Oncology 34, S1601, 2023 | | 2023 |
